Account Info
Log Out
English
Back
Log in to access Online Inquiry
Back to the Top

Update

$Scilex Holding (SCLX.US)$ Scilex Announced It Had A Successful End Of Phase II Meeting With The FDA Leading To An Agreed Path Forward To NDA Upon Completion Of Phase III Trials For Blockbuster Product Candidate, SP-103 (Lidocaine Topical System) 5.4% For The Treatment Of Chronic Neck Pain Associated With Muscle Spasms
Disclaimer: Community is offered by Moomoo Technologies Inc. and is for educational purposes only. Read more
4
+0
2
Translate
Report
1991 Views
Comment
Sign in to post a comment
3432Followers
27Following
51KVisitors
Follow